Universidad Autonoma de Madrid. Hospital Universitario La Paz

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer	Intermediate Risk Non-Muscle Invasive Bladder Cancer	Recruiting	Phase 3	2026-10-07		NCT06510374
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer	Non-muscle Invasive Bladder Cancer With Carcinoma in Situ	Recruiting	Phase 3	2026-09-25		NCT06545955

Clinical trials